These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1960859

  • 1. [Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
    Kitamura K, Takaku F, Miyazaki T, Miura, Mizoguchi H, Saito H, Masaoka T, Kimura I, Niho Y.
    Jpn J Antibiot; 1991 Sep; 44(9):979-86. PubMed ID: 1960859
    [Abstract] [Full Text] [Related]

  • 2. [Treatment with sulbactam/cefoperazone of severe infections in patients with hematological disorders].
    Ohno R, Hotta T, Ogura M, Ohnishi K, Morishita T, Murate T, Okumura M, Tanimoto M, Inoue C, Hamaguchi M.
    Jpn J Antibiot; 1989 Aug; 42(8):1713-9. PubMed ID: 2810734
    [Abstract] [Full Text] [Related]

  • 3. [A combined consecutive therapy with fosfomycin and sulbactam/cefoperazone for bacterial infections associated with hematological diseases].
    Misawa S, Tsuda S, Taniwaki M, Horiike S, Ariyama Y, Hirakawa K, Ueda Y, Kaneko H, Nakao M, Kashima K.
    Jpn J Antibiot; 1995 Apr; 48(4):514-21. PubMed ID: 7540219
    [Abstract] [Full Text] [Related]

  • 4. [Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
    Fukuda M, Hirashima K.
    Jpn J Antibiot; 1993 Oct; 46(10):912-7. PubMed ID: 8254893
    [Abstract] [Full Text] [Related]

  • 5. [A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
    Takashima T, Tsuda S, Misawa S, Horiike S, Kuzuyama Y, Hirakawa K, Nakai H, Seriu T, Tanaka S, Nishida K.
    Jpn J Antibiot; 1993 Mar; 46(3):251-8. PubMed ID: 8510322
    [Abstract] [Full Text] [Related]

  • 6. [Clinical evaluation of sulbactam/cefoperazone in lower respiratory tract infections].
    Ishibashi T, Takamoto M, Shinoda A, Yoshida M, Ichikawa Y, Kido M, Ninomiya K, Kitahara Y, Hara N, Tsurutani H.
    Jpn J Antibiot; 1990 Feb; 43(2):239-56. PubMed ID: 2194054
    [Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections].
    Sukoh M, Inoue T, Morita Y, Ito K, Togano Y, Yamanaka K, Hirose S, Takahashi T, Mita S, Mano K.
    Jpn J Antibiot; 1994 Feb; 47(2):170-80. PubMed ID: 8151910
    [Abstract] [Full Text] [Related]

  • 8. [Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
    Matsushima T, Tamura K, Okamoto K, Kawada E, Murayama K, Maehara T, Sadakata H, Tamura J, Sawamura M, Morita K.
    Jpn J Antibiot; 1993 Aug; 46(8):697-705. PubMed ID: 8230737
    [Abstract] [Full Text] [Related]

  • 9. [Multicenter study of the effects of sulbactam/cefoperazone on bacterial infections in the fields of internal medicine focused mainly on respiratory infections in Tochigi Prefecture].
    Motojima S, Asakawa J, Ezure M, Tateishi K, Nakajima H, Hirata S, Sagara H, Arima M, Akutsu I, Fukuda T.
    Jpn J Antibiot; 1993 Oct; 46(10):918-25. PubMed ID: 8254894
    [Abstract] [Full Text] [Related]

  • 10. [Clinical experience with chemotherapy using sulbactam/cefoperazone for severe infections accompanying malignant hematological disorders].
    Fujii Y, Ayame H, Inoue H, Fujita N, Miyoshi K, Murano K, Hatao K, Yaga K, Kaku K, Kaneko T.
    Jpn J Antibiot; 1990 Jun; 43(6):1143-51. PubMed ID: 2232145
    [Abstract] [Full Text] [Related]

  • 11. [An evaluation of combination antibiotic therapy in infections with hematological disorders. Hyogo Cooperative Study Group of Infectious Diseases Complicating Hematological Disorders].
    Takemoto Y, Kanamaru A, Kakishita E, Nakayama S, Hara H, Yamaguchi N, Tsutsui T, Mitsutani S, Tago H, Sonoda T.
    Jpn J Antibiot; 1991 Mar; 44(3):296-302. PubMed ID: 1880911
    [Abstract] [Full Text] [Related]

  • 12. [Clinical evaluation of sulbactam/cefoperazone for infections during the chemotherapy of hematologic malignancy].
    Kawai Y, Ueda T, Iwasaki H, Nakamura T.
    Jpn J Antibiot; 1994 Sep; 47(9):1196-201. PubMed ID: 7990260
    [Abstract] [Full Text] [Related]

  • 13. [Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
    Toyama K, Torii Y, Aoki I, Kikuchi M, Wakasugi K.
    Jpn J Antibiot; 1992 Aug; 45(8):1003-8. PubMed ID: 1433888
    [Abstract] [Full Text] [Related]

  • 14. [Studies on sulbactam/cefoperazone in the field of pediatrics].
    Iwai N, Taneda Y, Shibata M, Mizoguchi F, Katayama M.
    Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Obata I, Ryu F, Imagawa N, Ochiai K, Koike K, Morimoto O, Hachiya S.
    Jpn J Antibiot; 1984 Dec; 37(12):2478-94. PubMed ID: 6098741
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
    Suzuki K, Horiba M.
    Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.